Ochsner Medical Center

Gayle Benson Makes Historic Donation for New Home for Ochsner Children's Hospital

Retrieved on: 
Friday, December 15, 2023
Human, Ochsner Medical Center, NICU, Cardiology, Gayle, Wayfinding, Hospital, Elective surgery, Patient, Multimedia, Ochsner Health System, Element, Movement, Caregiver, Health, Emotion, Child, News, Work, Nursing care plan, Family, Parent, Physician, Children's Hospital, Pelican, Operating, Travel, Nursing, Toy, Ochsner

NEW ORLEANS, Dec. 15, 2023 /PRNewswire/ -- Ochsner Health announces plans for The Gayle and Tom Benson Ochsner Children's Hospital, made possible through a transformational gift from Mrs. Gayle Benson.

Key Points: 
  • NEW ORLEANS, Dec. 15, 2023 /PRNewswire/ -- Ochsner Health announces plans for The Gayle and Tom Benson Ochsner Children's Hospital, made possible through a transformational gift from Mrs. Gayle Benson.
  • "I am truly humbled to announce today The Gayle and Tom Benson Ochsner Children's Hospital," said Gayle Benson, New Orleans Saints Owner and Pelicans Governor.
  • Ochsner has become a national healthcare leader and destination for patients seeking medical care in virtually every discipline.
  • The Gayle and Tom Benson Ochsner Children's Hospital is designed to have a child-friendly and welcoming atmosphere, with colorful and engaging decor, age-appropriate accommodations, and an efficient, easy-to-navigate layout.

T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel

Retrieved on: 
Tuesday, September 19, 2023
Ochsner Medical Center, ASPR, Burkholderia pseudomallei, Plague, Emergency, Biomedical Advanced Research and Development Authority, CBRN, Office of Inspector General, U.S. Department of Health and Human Services, HHS, Administration for Strategic Preparedness and Response, Public, Infection, Tularemia, Public Health Service Act, Unitary state, Typhus, Biosafety, Glanders, Yersinia pestis, Government, Melioidosis, Bacillus anthracis, Burkholderia mallei, Development, Administration, Disaster, MRIGlobal, Francisella tularensis, Biological warfare, Public health, Patient, Rickettsia prowazekii, Bacillus, Mortality, FDA, Anthrax, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, BARDA, Food, Pharmaceutical industry, Vaccine, Medical device

LEXINGTON, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the T2Biothreat™ Panel.

Key Points: 
  • LEXINGTON, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the T2Biothreat™ Panel.
  • The FDA 510(k) clearance allows the company to immediately begin marketing and selling the T2Biothreat Panel in the U.S. market.
  • The U.S. clinical evaluation to support the FDA 510(k) submission included testing of the T2Biothreat Panel at MRIGlobal, a Biosafety Level 3 laboratory specializing in biothreat pathogens, and Ochsner Medical Center.
  • The T2Biothreat Panel is able to detect the six aforementioned biothreat pathogens within four hours providing clinicians with the needed information to appropriately treat infected patients.

Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast

Retrieved on: 
Monday, January 10, 2022
Public health, Health, Kidney disease, Ochsner Medical Center, Risk, Blue Cross Blue Shield Association, LinkedIn, DKD, Dialysis, Chronic kidney disease, Patient, Centers for Disease Control and Prevention, Physician, General Services Administration, LSE, Hospital, Gulf Coast of the United States, Type 2 diabetes, NASDAQ, Work, Insurance, Center, Instagram, Precision medicine, Partnership, Midwifery, Patient safety, Food, SALT, Black, Biomarker, Conditional sentence, Mississippi Gulf Coast, Diabetes, Gulf, YouTube, Singing, CKD, Breast, Prognosis, Twitter, GLOBE, Population, CDC, Regulation of tobacco by the U.S. Food and Drug Administration, Pharmaceutical industry, Medicaid, Facebook, Pascagoula River

and SALT LAKE CITY, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singing River Health System and Renalytix (NASDAQ: RNLX) (LSE: RENX) today announced a partnership to deploy KidneyIntelX informed care management to improve kidney health in individuals with type 2 diabetes and early-stage chronic kidney disease.

Key Points: 
  • and SALT LAKE CITY, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singing River Health System and Renalytix (NASDAQ: RNLX) (LSE: RENX) today announced a partnership to deploy KidneyIntelX informed care management to improve kidney health in individuals with type 2 diabetes and early-stage chronic kidney disease.
  • Singing River is a mission-driven healthcare provider with locations spanning across the Mississippi Gulf Coast, a region with one of the highest rates of diabetes in the country.
  • Racial and economic disparities in care greatly contribute towards this unmistakable health and financial burden in our community, said Victoria Lewandrowski, System Laboratory Relations Manager, Singing River.
  • Singing River Health System is the first partner located along the Gulf Coast for Renalytix.

Nektar Therapeutics Announces Data Presentations for its Immuno-Oncology Programs at the European Society for Medical Oncology Immuno-Oncology (ESMO-IO) Congress 2021 and the 63rd American Society of Hematology (ASH) Annual Meeting

Retrieved on: 
Tuesday, November 30, 2021
NSCLC, Oncology, MD Anderson Cancer Center, Assistant professor, Internal medicine, Melanoma, School, Gayle, NKTR, Risk, Nektar, Norris Cotton Cancer Center, Immunotherapy, Division, Congress, Department, Nektar Therapeutics, Head, Tumor microenvironment, University, LSU, Pembrolizumab, Research, American Board of Commissioners for Foreign Missions, Hematology, PROPEL, Failure, Medical school, Louisiana State University, José Felipe Flores, Forward-looking statement, Large-cell lung carcinoma, Lymphocyte, Virology, NASDAQ, ASH, Society, European Society for Medical Oncology, Abstract, Therapy, Ochsner Medical Center, Safety, American Board of Internal Medicine, Lung cancer, Financial toxicity, SAN, Patent, Webcast, Lithium, Pharmaceutical industry

In addition, two clinical data presentations for NKTR-255 in patients with relapsed/refractory hematologic malignancies will be presented during the 63rd American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia from December 11 to December 14, 2021.

Key Points: 
  • In addition, two clinical data presentations for NKTR-255 in patients with relapsed/refractory hematologic malignancies will be presented during the 63rd American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia from December 11 to December 14, 2021.
  • ePoster will be on display on the ESMO-IO 2021 virtual meeting platform on Monday, December 6, 2021, at 12:00 pm GMT (7:00 a.m.
  • ePoster will be on display on the ASH 2021 virtual meeting platform on Sunday, December 12, 2021, at 6:00 a.m.
  • The event will follow the publication of the NKTR-214 (BEMPEG) PROPEL poster (Abstract #140P) on Monday, December 6, 2021.

Erin Dauterive, MD is recognized by Continental Who's Who

Retrieved on: 
Friday, October 8, 2021
BATON, Prescription, OBGYN, Gynaecology, Obstetrics, Physician, Ochsner Medical Center, Multimedia, American Board of Obstetrics and Gynecology, Louisiana State University, MD, Health, American Board of Commissioners for Foreign Missions, Continental, Professional, Patient, Trust (social science), Hospital, Medicine

BATON ROUGE, La., Oct. 8, 2021 /PRNewswire/ --Erin Dauterive, MD, is being recognized by Continental Who's Who as a Trusted OBGYN for her outstanding achievements in the medical field and her devotion to the medical community through her services at Ochsner Medical Center O'Neal.

Key Points: 
  • BATON ROUGE, La., Oct. 8, 2021 /PRNewswire/ --Erin Dauterive, MD, is being recognized by Continental Who's Who as a Trusted OBGYN for her outstanding achievements in the medical field and her devotion to the medical community through her services at Ochsner Medical Center O'Neal.
  • Committed to offering the best possible care, the Ochsner Medical Center O'Neal is situated at 16777 Medical Center Drive in Baton Rouge, Louisiana.
  • The dedicated physicians provide primary care and a number of specialty care services all in one convenient location.
  • Same-day appointments are available, and Ochsner makes it easy for you to fill your prescriptions at its onsite pharmacy.

Podium and Ochsner Health Partner To Enhance Post Visit Communications

Retrieved on: 
Tuesday, April 20, 2021
Ochsner, Healthcare in New Orleans, LOUISIANA, Ochsner Medical Center, Healthcare in the United States, Ochsner Health System

Ochsner Health is a national leader, named the top hospital in Louisiana and a top children\'s hospital by U.S. News & World Report.

Key Points: 
  • Ochsner Health is a national leader, named the top hospital in Louisiana and a top children\'s hospital by U.S. News & World Report.
  • As Louisiana\'s leading healthcare educator, Ochsner Health and its partners educate thousands of healthcare professionals annually.
  • Ochsner Health is innovating healthcare by investing in new technologies and research to make world-class care more accessible, affordable, convenient and effective.
  • To learn more about Ochsner Health, please visit www.ochsner.org .\nView original content to download multimedia: http://www.prnewswire.com/news-releases/podium-and-ochsner-health-partne...\n'

Brookwood Properties opens new self-storage facility in New Orleans, LA

Retrieved on: 
Thursday, April 15, 2021
Geography of Louisiana, LOUISIANA, Geography of the United States, Healthcare in New Orleans, Ochsner Medical Center, Ochsner, Baton Rouge, Louisiana, Jefferson Parish, Louisiana, Jefferson Highway, New Orleans

b"NEW ORLEANS, April 15, 2021 /PRNewswire/ -- Brookwood Properties, ofBaton Rouge, LA, announces the opening of its latest facility located at445 Jefferson Highway, New Orleans, LA 70121.\nThe three-story, class A facility comprises approximately 110,500 rentable square feet and over 1100 climate-controlled units.

Key Points: 
  • b"NEW ORLEANS, April 15, 2021 /PRNewswire/ -- Brookwood Properties, ofBaton Rouge, LA, announces the opening of its latest facility located at445 Jefferson Highway, New Orleans, LA 70121.\nThe three-story, class A facility comprises approximately 110,500 rentable square feet and over 1100 climate-controlled units.
  • The facility, managed by Life Storage ofBuffalo, NY, is located at the Orleans and Jefferson Parish line and near Ochsner Medical Center.\nThe project represents Brookwood's 40thfacility in Louisiana and 11th in the New Orleans area.
  • Baton Rouge, LAbased Rosehill Construction served as the General Contractor andWichita, KSbased Kaufman Design was the architect.\n"

Ochsner LSU Health Shreveport And Oceans Healthcare Open New Behavioral Health Facility

Retrieved on: 
Wednesday, January 20, 2021
LOUISIANA, Louisiana State University System, Ochsner, V-12 Navy College Training Program, LSU Health Sciences Center Shreveport, Shreveport, Louisiana, Louisiana State University, Healthcare in New Orleans, Ochsner Health System, Ochsner Medical Center

SHREVEPORT, La., Jan. 20, 2021 /PRNewswire/ -- Ochsner LSU Health Shreveport and Oceans Healthcare today announced the opening of Louisiana Behavioral Health .

Key Points: 
  • SHREVEPORT, La., Jan. 20, 2021 /PRNewswire/ -- Ochsner LSU Health Shreveport and Oceans Healthcare today announced the opening of Louisiana Behavioral Health .
  • We look forward to creating meaningful change at Louisiana Behavioral Health with Ochsner LSU Health Shreveport and improving lives by making behavioral health care more accessible."
  • ABOUT OCHSNER LSU HEALTH SHREVEPORT:
    On Oct. 1, 2018, Ochsner Health (Ochsner) and LSU Health Shreveport jointly formed Ochsner LSU Health Shreveport to oversee and coordinate activities between the health sciences center and the healthcare delivery system in Shreveport and Monroe, La.Ochsner LSU Health Shreveport is a public-private partnership with a vision to improve health and well-being of its communities, access to care, quality, and facilities, expand patient-centered technology, grow the medical school, and enhance research in North Louisianaby building on the strengths of Ochsner and LSU Health Shreveport.
  • With more than 4,000 employees and the Ochsner LSU Health Shreveport Physician Group of approximately 500 physicians, Ochsner LSU Health Shreveport serves more than 140,000 patients with more than 625,000 visits annually.

Ochsner Health First Healthcare System to Go-Live with Vynca and Louisiana Health Care Quality Forum's Statewide Electronic Registry for LaPOST Forms

Retrieved on: 
Tuesday, January 5, 2021
Health, Health informatics, Primary care, Health information exchange, Health care quality, Health care, Ochsner, Patient safety organization, Ochsner Medical Center

The partnership between the Quality Forum and Vynca enables healthcare providers in all care settings across Louisiana to electronically complete and access patients' LaPOST forms.

Key Points: 
  • The partnership between the Quality Forum and Vynca enables healthcare providers in all care settings across Louisiana to electronically complete and access patients' LaPOST forms.
  • Vynca is proud to partner with Louisiana Health Care Quality Forum and Ochsner Health to make real-time visibility into a patient's true care goals a reality."
  • The Louisiana Health Care Quality Forum is a private, not-for-profit organization dedicated to advancing evidence-based initiatives to improve the health and health care of Louisiana residents.
  • The Quality Forum serves as the State-Designated Entity for health IT initiatives in Louisiana, including management of the statewide health information exchange.

LHC Group and Ochsner Health System announce acquisition expanding partnership

Retrieved on: 
Wednesday, December 18, 2019
Ochsner Health System, Ochsner, Healthcare in New Orleans, Large Hadron Collider, Physics, Laboratories, LOUISIANA, Ochsner Medical Center

LAFAYETTE, La., Dec. 18, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) and Ochsner Health System (Ochsner) announced an expansion of their joint venture partnership Southeast Louisiana HomeCare with an agreement to purchase five Egan Home Health and Hospice provider locations across South Louisiana.

Key Points: 
  • LAFAYETTE, La., Dec. 18, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) and Ochsner Health System (Ochsner) announced an expansion of their joint venture partnership Southeast Louisiana HomeCare with an agreement to purchase five Egan Home Health and Hospice provider locations across South Louisiana.
  • We are excited by this opportunity to expand our current joint venture agreement with a respected healthcare partner like Ochsner Health System, said Keith Myers, LHC Group chairman and CEO.
  • Our partnership with LHC Group allows Ochsner to care for more patients in ways beyond our traditional hospital and clinic setting.
  • Through their partnership, LHC Group and Ochsner focus on expanding access to in-home healthcare service capacity and capabilities in key markets.